National Pharmaceutical Pricing Authority Current Affairs, GK & News
The National Pharmaceutical Pricing Authority, in collaboration with the Karnataka State Drug Control Department, has launched the Price Monitoring and Resource Unit in the state. The PMRU will be mainly responsible for making access to medicine convenient for all the citizens of the state. Details of the PMRU The PMRU will have the first-ever governing ..
Topics: CAPPM • Consumer Awareness Publicity and Price Monitoring • DPCO • Drug Prices Control Order • Karnataka • National Pharmaceutical Pricing Authority • NPPA • PMRU • Price Monitoring and Resource Unit
On April 1, 2020, the National Pharmaceutical Pricing Authority revised the ceiling price of 883 scheduled formulations. The authority also informed that the disruption of supply of Active Pharmaceutical Ingredients are returning to normalcy. Highlights The NPPA has notified 24 classes of medical devices as drugs under Drugs and Cosmetics Act, 1940. The prices of ..
Category: India Nation & States Current Affairs
Government has notified that ceiling price of orthopaedic knee implants will be monitored to ensure that their cost does not increase beyond 10% in a given year. Background Earlier on 16 August 2017, National Pharmaceutical Pricing Authority (NPPA) notified ceiling price of orthopaedic knee implants by invoking extraordinary powers, in public interest, under Para 19 ..
Topics: Ceiling Price • Drugs Prices Control Order (DPCO) 2013 • Essential Commodities Act • Knee Implant • National Pharmaceutical Pricing Authority • Orthopaedic knee implants • Union Ministry of Chemicals and Fertilizers
The National Pharmaceutical Pricing Authority (NPPA) has slashed the prices of 9 non-scheduled cancer drugs by up to 87 per cent as part of its efforts to bring down drugs prices. The move is expected to curb profiteering on these vital drugs and to make cancer cure affordable for patients and their families. National Pharmaceutical Pricing ..
The National Pharmaceutical Pricing Authority (NPPA) has reduced the prices of 9 non-scheduled cancer drugs by up to 87%. This decision is in continuation of nodal agency’s efforts to bring down drugs prices. Key Facts Reason: In February 2019, the government had capped about 42 cancer drugs at 30%. This new anti-cancer non-scheduled medicine list ..
Month: Current Affairs - May, 2019
Category: Economy & Banking Current Affairs
Topics: Anti-cancer drugs • Cancer drugs • Department of Pharmaceuticals • Drug Price Control Orders • Drug Pricing • Ministry of Chemicals & Fertilizers • national list of essential medicines • National Pharmaceutical Pricing Authority • NLEM • NPPA